Therefore, combined with the expression levels of these hub genes in the GSE30933 dataset, we assume that the downregulation of CD28, FAS, and IFIT5 might be potential diagnostic biomarkers for FRDA progression. The gene discussed is FAS; the disease is Friedreich ataxia.